We are live on ! Find out more
HUMAW icon

Humacyte Inc Warrant

10 hedge funds and large institutions have $448K invested in Humacyte Inc Warrant in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.15% more ownership

Funds ownership: 0.75%0.9% (+0.15%)

0% more funds holding

Funds holding: 1010 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

54% less capital invested

Capital invested by funds: $971K → $448K (-$523K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
4
Closed
2
Calls
$118K
Puts
Net Calls
+$118K
Net Calls Change
-$214K
Name Holding Trade Value Shares
Change
Change in
Stake
LP
1
LMR Partners
United Kingdom
$106K
JAIC
2
Josh Arnold Investment Consultant
Minnesota
$93K +$210K +237,693 New
LPL Financial
3
LPL Financial
California
$87.8K +$26.5K +30,000 +15%
CH
4
CVI Holdings
Delaware
$78.1K -$31K -35,118 -15%
RL
5
RPO LLC
Connecticut
$22.3K -$23.9K -27,000 -32%
Jane Street
6
Jane Street
New York
$22.2K -$93 -105 -0.2%
HF
7
HRT Financial
New York
$13K -$6.69K -7,568 -18%
ETH
8
Exos TFP Holdings
New York
$10.7K
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$7.89K +$17.8K +20,102 New
PSAMP
10
P. Schoenfeld Asset Management (PSAM)
New York
$7.52K
SCM
11
Sio Capital Management
New York
-$58K -49,998 Closed
Verition Fund Management
12
Verition Fund Management
Connecticut
-$18K -15,000 Closed

HUMAW Hedge Fund Activity: Q4 2022 in Review

10 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q4 2022, worth a combined $448K — down 54% from $971K a quarter earlier.

Fund positioning in HUMAW was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 4 trimmed.

The largest buyer was Josh Arnold Investment Consultant, opening a new position worth an estimated $210K. The largest seller was Sio Capital Management, exiting entirely with an estimated $58K sold.

  • 10 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $448K of Humacyte Inc Warrant stock for Q4 2022, down 54% quarter-over-quarter.
  • 2 funds opened new Humacyte Inc Warrant positions in Q4 2022 and 2 closed out, a net change of 0 holders.
  • The largest Humacyte Inc Warrant buyer in Q4 2022 was Josh Arnold Investment Consultant, an estimated $210K added.
  • The largest Humacyte Inc Warrant seller in Q4 2022 was Sio Capital Management, an estimated $58K sold.

Based on aggregated 13F filings for Q4 2022.